by Richard Daverman, PhD
January 9, 2012 -- Guangdong Dahuanong Animal Health Products will purchase a 60% stake in Foshan Standard Bio-tech Co., Ltd., a fellow veterinary products company, paying 158 million RMB ($25.4 million). Dahuanong said the acquisition would add products to its portfolio, especially a chicken coccidiosis vaccine. Foshan Standard makes pharmaceutical preparations and feed additives, as does Dahuanong. More details....
Stock Symbol: (SHE: 300186)
